InVivo Therapeutics to Present at 2017 BIO CEO & Investor Conference
February 07 2017 - 8:00AM
Business Wire
InVivo Therapeutics Holdings Corp. (NVIV) today
announced that Mark Perrin, Chief Executive Officer and Chairman,
will present at the 2017 BIO CEO & Investor Conference on
Monday, February 13, 2017 at 11:30 A.M. Eastern Time at the Waldorf
Astoria in New York, NY. Mr. Perrin will highlight the recent
progress of the Company’s Neuro-Spinal Scaffold™ program, and
provide an overview of the Company.
A live webcast will be available at
http://www.veracast.com/webcasts/bio/ceoinvestor2017/56115496336.cfm
and a webcast replay will be available at the same address
approximately one hour after the live webcast presentation. Please
log in approximately 5-10 minutes before the event to ensure a
timely connection.
The BIO CEO & Investor Conference is one of the largest
investor conferences focused on established and emerging publicly
traded and select private biotech companies and will take place at
the Waldorf Astoria February 13 – 14, 2017.
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a research and
clinical-stage biomaterials and biotechnology company with a focus
on treatment of spinal cord injuries. The company was founded in
2005 with proprietary technology co-invented by Robert Langer,
Sc.D., Professor at Massachusetts Institute of Technology, and
Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital
and who now is affiliated with Massachusetts General Hospital. In
2011, the company earned the David S. Apple Award from the American
Spinal Injury Association for its outstanding contribution to
spinal cord injury medicine. In 2015, the company’s investigational
Neuro-Spinal Scaffold received the 2015 Becker’s Healthcare Spine
Device Award. The publicly-traded company is headquartered in
Cambridge, MA. For more details, visit
www.invivotherapeutics.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170207005407/en/
InVivo TherapeuticsBrian Luque, 617-863-5535Investor
Relationsbluque@invivotherapeutics.com
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Mar 2024 to Apr 2024
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Apr 2023 to Apr 2024